A Confirmatory Efficacy Trial of Engaging a Novel Sleep/Circadian Rhythm Target as Treatment for Depression in Adolescents
TranS-C
+ Psychoeducation
Behavior
+ Behavioral Symptoms
+ Depression
Treatment Study
Summary
Study start date: March 15, 2024
Actual date on which the first participant was enrolled.This study focuses on helping teenagers who suffer from depression and have a mismatch between their internal body clock and the time they wake up. The researchers are interested in seeing if adjusting this relationship can lead to better outcomes for these young people. By targeting this specific aspect, the study aims to find new ways to aid adolescents struggling with depression, potentially providing a novel method for improving their mental health. Participants in the study will undergo a cognitive-behavioral sleep intervention, which is a structured program designed to improve sleep patterns and, in turn, mood. The intervention will involve strategies to help align their biological clock with a healthier waketime. Although the study doesn't specify how results will be measured, the goal is to assess if these changes lead to a noticeable improvement in depression symptoms. This research could offer valuable insights into a new avenue for treating depression in adolescents by focusing on their sleep and circadian rhythms.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.200 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 12 to 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
UCSF Nancy Friend Pritzker Psychiatry Building
San Francisco, United StatesOpen UCSF Nancy Friend Pritzker Psychiatry Building in Google Maps